New insider activity at National Healthcare ( (NHC) ) has taken place on November 26, 2025.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Director Emil Hassan has recently sold 7,500 shares of National Healthcare stock, amounting to a significant transaction valued at $1,038,825.
Recent Updates on NHC stock
In recent developments, National Healthcare Corporation (NHC) has made significant leadership changes, appointing Dr. Lisa Piercey to its Board of Directors and announcing Stephen F. Flatt as the new CEO and President. These changes are part of a strategic move to strengthen the company’s leadership team. Additionally, NHC declared a quarterly dividend of 64 cents per share, reflecting its stable financial position and commitment to shareholder value. Analysts have issued a ‘Buy’ rating for NHC, supported by the company’s strong financial performance, robust balance sheet, and solid technical indicators, although some caution is advised due to potential overvaluation signals. The company’s market cap is noted at approximately $2.03 billion, with a strong buy technical sentiment signal.
Spark’s Take on NHC Stock
According to Spark, TipRanks’ AI Analyst, NHC is a Outperform.
National Healthcare’s stock is supported by solid financial performance and strong technical indicators, though the valuation suggests it may be slightly overvalued. The company’s strong balance sheet and operational efficiency are key strengths, while the technical analysis indicates potential for continued momentum, albeit with caution due to overbought signals.
To see Spark’s full report on NHC stock, click here.
More about National Healthcare
YTD Price Performance: 30.55%
Average Trading Volume: 70,165
Technical Sentiment Signal: Buy
Current Market Cap: $2.14B